These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28012875)

  • 41. Oxygen care and treatment of retinopathy of prematurity in ocular and neurological prognosis.
    Kang HG; Choi EY; Cho H; Kim M; Lee CS; Lee SM
    Sci Rep; 2022 Jan; 12(1):341. PubMed ID: 35013470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.
    Ekinci DY; Çelik K
    J Pediatr Ophthalmol Strabismus; 2020 Jan; 57(1):54-60. PubMed ID: 31972042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Presentation and Management Outcomes of Coexistent Congenital Glaucoma and Retinopathy of Prematurity.
    Senthil S; Balijepalli P; Garudadri C; Jalali S
    J Glaucoma; 2019 Jan; 28(1):20-26. PubMed ID: 30461550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
    Kaempfen S; Neumann RP; Jost K; Schulzke SM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Playing With Fire.
    Harper CA; Beck KD; Chang E; Young R; Moshfeghi DM
    Ophthalmic Surg Lasers Imaging Retina; 2020 Oct; 51(10):542-544. PubMed ID: 33104220
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinopathy of prematurity.
    Dammann O; Hartnett ME; Stahl A
    Dev Med Child Neurol; 2023 May; 65(5):625-631. PubMed ID: 36408783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-invasive Respiratory Support and Severe Retinopathy of Prematurity.
    Raghu R; Fisher M; Cerone J; Barry G
    J Pediatr Ophthalmol Strabismus; 2016 Aug; 53():e47-50. PubMed ID: 27537495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aggressive posterior retinopathy of prematurity in two cohorts of patients in South India: implications for primary, secondary, and tertiary prevention.
    Shah PK; Subramanian P; Venkatapathy N; Chan RVP; Chiang MF; Campbell JP
    J AAPOS; 2019 Oct; 23(5):264.e1-264.e4. PubMed ID: 31521847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SAFER-ROP: Updated Protocol for Anti-VEGF Injections for Retinopathy of Prematurity.
    Beck KD; Rahman EZ; Ells A; Mireskandari K; Berrocal AM; Harper CA
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jul; 51(7):402-406. PubMed ID: 32706898
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
    Erol N; Gürsoy H; Sahin A; Basmak H
    J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New therapeutic approaches in the treatment of retinopathy of prematurity].
    Jandeck C
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FACTORS ASSOCIATED WITH REACTIVATION AFTER INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB THERAPY IN INFANTS WITH RETINOPATHY OF PREMATURITY.
    Iwahashi C; Utamura S; Kuniyoshi K; Sugioka K; Konishi Y; Wada N; Kusaka S
    Retina; 2021 Nov; 41(11):2261-2268. PubMed ID: 33958533
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?
    Spandau U; Tomic Z; Ewald U; Larsson E; Akerblom H; Holmström G
    Acta Ophthalmol; 2013 Mar; 91(2):170-5. PubMed ID: 22268644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hot Topics in Retinopathy of Prematurity.
    Tsui I; Chu A
    Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reactivation of Retinopathy of Prematurity in Adults and Adolescents.
    Uner OE; Rao P; Hubbard GB
    Ophthalmol Retina; 2020 Jul; 4(7):720-727. PubMed ID: 32224099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF).
    Tsai AS; Chou HD; Ling XC; Al-Khaled T; Valikodath N; Cole E; Yap VL; Chiang MF; Chan RVP; Wu WC
    Prog Retin Eye Res; 2022 May; 88():101018. PubMed ID: 34763060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy.
    Kuo HK; Sun IT; Chung MY; Chen YH
    Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
    Mintz-Hittner HA; Kennedy KA; Chuang AZ;
    N Engl J Med; 2011 Feb; 364(7):603-15. PubMed ID: 21323540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.